Uncategorized

Bordetella pertussis infections continue to rise! In contrast to the time before and during the Covid pandemic, we are currently seeing alarmingly high numbers of respiratory infections caused by [...]

Please note: The proof of chlamydia trachomatis serotypes L1- L3 is to be reported since September 2022 We would like to draw your attention to the crucial importance of differentiating between [...]

Dramatic rise in syphilis infections: Warning of underestimated risk In recent years, the healthcare world has seen a concerning surge in syphilis infections. Between 2020 and 2022, reported [...]

The EU has created a new legal framework for the quality and safety of in-vitro medical devices, namely the IVDR (Regulation on in-vitro diagnostic medical devices), which sets legally binding [...]

Mississauga, Canada and Darmstadt, Germany, 15th May  2020 – R-Biopharm AG  and Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator, announces the appointment of R-Biopharm [...]